Centro médico Anadolu
Centro médico Anadolu
Turquía, Estambul
Zafer Gulbas
49 años de experiencia • 3315+ tratamientos realizados
acreditaciones :
Clínica certificada por :
El costo total del tratamiento de mieloma en Turquía depende de su plan de tratamiento. Los diagnósticos iniciales, que incluyen análisis de sangre completos y biopsia de médula ósea, varían de 3.000 € a 6.100 €. Las pruebas genéticas y la tipificación HLA cuestan aproximadamente 1.700 €. Los protocolos de quimioterapia, como VTd, pueden costar entre 6.300 € y 15.700 €. El trasplante autólogo de células madre tiene un precio de 28.500 € a 33.200 €. El programa de tratamiento se determina después de una evaluación individual de cada paciente.
| España | Turquía | México | |
| Plasmaféresis | de $1,800 | de $1,200 | de $1,100 |
| Plasmaféresis DFPP | - | de $1,850 | - |
| Intercambio de plasma | - | de $3,900 | - |
| Aféresis terapéutica | - | de $1,350 | - |
El Prof. Zafer Gulbas fundó el Centro de Trasplante de Médula Ósea de Anadolu y es el principal hematólogo-oncólogo de Turquía.
El Dr. Bülent Karagöz es un destacado oncólogo médico turco con más de 20 años de experiencia, especializado en biología tumoral e inmunoterapia.
Formado en la Mayo Clinic – El Dr. Sevindik aporta una experiencia de primer nivel en hematología al Hospital Florence Nightingale de Estambul.
El profesor Bulent Eser aporta 29 años de experiencia en hematología, especializándose en mieloma en el Medical Park Antalya Hospital Complex.
Turkey is a leading myeloma treatment hub offering JCI-accredited care and advanced hematology units. Facilities like Anadolu Medical Center provide autologous stem cell transplantation and modern drug therapies. Patients access specialized centers with high success rates and no waiting lists for urgent blood disorder treatments.
Bookimed Expert Insight: Turkish hematology centers demonstrate exceptional depth in bone marrow transplantation. Dr. Zafer Gulbas at Anadolu Medical Center reports an 81% success rate for autologous transplants. This high performance likely stems from performing over 3,300 specialized procedures. Patients benefit from this concentrated surgical expertise often found in top-tier Istanbul hospitals.
Patient Consensus: Patients emphasize the high efficiency of medical staff and the quality of care. They note that the coordination between doctors and international departments makes the treatment process smooth.
Turkish clinics offer advanced hematology-oncology treatments including bone marrow transplants, targeted therapies, and immunotherapy. JCI-accredited centers like Anadolu Medical Center and Memorial Health Group utilize multidisciplinary teams for myeloma. Specialized care involves academic protocols developed in partnership with institutions like Johns Hopkins Medicine.
Bookimed Expert Insight: While many clinics offer general oncology, Turkish centers with higher patient volumes, like Anadolu Medical Center or Medipol Mega, provide concentrated expertise in blood disorders. Prof. Dr. Zafer Gulbas at Anadolu has managed over 3,300 transplant procedures. Choosing a hospital based on specific hematology-oncology department size rather than general clinic fame often leads to better coordinated care.
Patient Consensus: Patients value the speed of appointment scheduling and the presence of dedicated international coordinators. They emphasize that bone marrow transplant infrastructure and English-speaking medical staff are critical factors for long-term treatment success.
Leading Turkish hospitals for myeloma treatment include Anadolu Medical Center, Memorial Şişli, and Medipol Mega University Hospital. These JCI-accredited centers specialize in autologous bone marrow transplants. They offer advanced diagnostics like sentinel lymph node biopsy and oncohematology consultations. Expert teams manage complex cases using international protocols.
Bookimed Expert Insight: Anadolu Medical Center stands out for myeloma care because of its 81% success rate in autologous transplants. High-volume centers like Medipol serve 1,000,000 patients yearly. This scale often reflects deeper experience in managing rare hematological complications than smaller clinics. We recommend prioritizing hospitals like Anadolu or Medipol that house dedicated bone marrow transplant units in-house.
Patient Consensus: Patients emphasize the value of having a full hematology team and suggest checking for English-speaking coordinators before traveling. They note that the quality of staff and doctors at centers like Anadolu and Medipol makes for an excellent experience.
Myeloma treatment in Turkey involves a multi-stage protocol. Intensive phases like stem cell transplants require a hospital stay of 3 to 4 weeks. Outpatient care, such as drug therapy or initial scans, allows for quicker returns. Patients usually spend several weeks in-country to monitor recovery and blood counts.
Bookimed Expert Insight: Anadolu Medical Center performs over 3,000 transplants with an 81% success rate. High-volume centers like this provide multidisciplinary tumor boards. These boards review complex cases to shorten the diagnostic phase. Choosing experienced teams helps streamline the transition from intensive care to outpatient recovery.
Patient Consensus: Patients emphasize the need for extra days in Turkey after finishing treatment. Travel is often difficult immediately after intensive therapy due to low blood counts and weakness.